De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation
Children's Health | Diseases of the Digestive System - Liver
What is the purpose of this trial?
The purpose of this study is to provide insights into the cause, development and effects of de novo autoimmune hepatitis so that prevention and treatment strategies can be developed in order to reduce post-liver transplant morbidity, the frequency of liver allograft loss and the need for re-transplantation.
- Ages3 months and older
- Trial withYale University School of Medicine
- Start Date03/14/2013
- End Date12/11/2018
- Last Updated03/07/2018
- Study HIC#1302011561